IRADIMED CORPORATION

US$86.31As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IRMDHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 25.90%
Div yield 0.93%
ROE 23.42%
Medical Devices
Beta (5Y) 0.94
PE TTM 46.16
TSR TTM 13.92%
Mkt cap US$1.104B
ROIC 51.83%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$97
12.26%
(68.06%)
Hold 2|0|1|12|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.39
1.40
1.49
1.54
29.59%
27.07%
25.47%
18.32%
Revenue$M
126.1
127.9
133.2
135.6
5.81%
8.33%
6.94%
9.43%
Peers (US$1.104B)
Cap (US$)
PE
1.094B
—
1.106B
412.0x
Capital
TTM
5Y
10Y
Leveragex
0.572
0.449
0.374
EBIT/Intx
1.545
0.151
0.159
Own earn%
(657.48)
(128.08)
(117.74)
Sh yield%
16.73
42.12
40.13
Owners
Insiders/Inst%
10.07
50.37
Short interest%
4.17
SBC / revenue%
5.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
6–9
$1 testx
—
Incr. ROIC%
3